CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies
CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing transplant diagnostics, specialty oncology and digital workflow integration. John H
CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing transplant diagnostics, specialty oncology and digital workflow integration.
John H
Relaterede artikler
23 min. siden
Soybeans Slip Lower on Tuesday, with Meal Pressure36 min. siden
Hog Slide Continues on Tuesday36 min. siden
Crude Oil Weakness Undercuts Sugar Prices36 min. siden
Hogs Extend Weakness to Tuesday, as Cutout Falls